Fox Chase Cancer Center News

Vladimir Kolenko, MD, PhD
October 29, 2018

Vladimir Kolenko Receives Grant from the Department of Defense to Study PARP-1 inhibitors in Renal Cell Carcinoma

PHILADELPHIA (October 29, 2018) – Vladimir Kolenko, MD, PhD, has received a grant from the Department of Defense to study histone-dependent PARP-1 inhibitors in the treatment of renal cell carcinoma. The objective of the proposal is to validate the therapeutic potential of novel PARP (poly ADP ribose polymerase)-1 inhibitors using clinically relevant cell and animal models of human clear cell renal cell carcinoma and investigate the mechanisms underlying their anti-tumor activity.

John Michael Daly, MD, FACS
October 23, 2018

John Michael Daly Admitted to American College of Surgeons’ Academy of Master Surgeon Educators™

PHILADELPHIA (October 23, 2018) – John Michael Daly, MD, FACS, a surgical oncologist at Fox Chase Cancer Center, is among a group of 91 esteemed surgeons from seven countries selected to the new American College of Surgeons (ACS) Academy of Master Surgeon Educators™. 

October 22, 2018

Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation, 11-Year Study Shows

PHILADELPHIA (October 22, 2018) – An analysis led by researchers at Fox Chase Cancer Center found that treating localized prostate cancer with hypofractionated intensity modulated radiation therapy (H-IMRT) yields equivalent disease outcomes compared with conventional intensity modulated radiation (C-IMRT).

October 21, 2018

Single Institution Analysis Shows Low Incidence of Short-Term Complications from Prostate Brachytherapy

PHILADELPHIA (October 21, 2018) – A new analysis of nearly 600 men who received brachytherapy for prostate cancer shows that overall incidence of complications related to the procedure within four months of treatment is less than 20 percent. All patients were treated at Fox Chase Cancer Center.

 Joan Font-Burgada, PhD
October 10, 2018

Scientists Identify Genetically Accurate Mouse Models in Hepatocellular Carcinoma

PHILADELPHIA (October 10, 2018)— Using a detailed analysis comparing the genetic and molecular makeup of tumors from nearly 1,000 patients with four common mouse models of hepatocellular carcinoma (HCC), researchers have identified animal models that most closely mimic human disease. 

October 4, 2018

Professor Jose Russo Honored with Hispanic Heritage Award

PHILADELPHIA (October 4, 2018) – Jose Russo, MD, FACP, director of the Irma H. Russo, MD, Breast Cancer Research Lab at Fox Chase Cancer Center, named by AL DÍA as one of nine recipients of their Hispanic Heritage Award for 2018.
October 2, 2018

Discovery of New Form of Cell Death Offers Clues to Controlling Bacterial Colonization in the Gut

PHILADELPHIA (October 2, 2018) — Observing how cells of the intestinal epithelium respond to Salmonella, scientists at Fox Chase Cancer Center have found a novel mechanism of cell death that shows a way to control the spread of bacteria.

October 2, 2018

Fox Chase Cancer Center Proudly Supports Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia 2018

PHILADELPHIA (October 2, 2018) – Fox Chase Cancer Center will again field a team  to raise funds at the Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia. The event will be held on Saturday, November 3 at Memorial Hall in Fairmount Park.


Connect with Fox Chase